These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28991460)

  • 1. A Smart Europium-Ruthenium Complex as Anticancer Prodrug: Controllable Drug Release and Real-Time Monitoring under Different Light Excitations.
    Li H; Xie C; Lan R; Zha S; Chan CF; Wong WY; Ho KL; Chan BD; Luo Y; Zhang JX; Law GL; Tai WCS; Bünzli JG; Wong KL
    J Med Chem; 2017 Nov; 60(21):8923-8932. PubMed ID: 28991460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time in situ monitoring via europium emission of the photo-release of antitumor cisplatin from a Eu-Pt complex.
    Li H; Lan R; Chan CF; Jiang L; Dai L; Kwong DW; Lam MH; Wong KL
    Chem Commun (Camb); 2015 Sep; 51(74):14022-5. PubMed ID: 26257074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photolabile ruthenium complexes to cage and release a highly cytotoxic anticancer agent.
    Wei J; Renfrew AK
    J Inorg Biochem; 2018 Feb; 179():146-153. PubMed ID: 29180165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bis(dipyridophenazine)(2-(2-pyridyl)pyrimidine-4-carboxylic acid)ruthenium(II) complex with anticancer action upon photodeprotection.
    Joshi T; Pierroz V; Mari C; Gemperle L; Ferrari S; Gasser G
    Angew Chem Int Ed Engl; 2014 Mar; 53(11):2960-3. PubMed ID: 24500767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human transport protein carrier for controlled photoactivation of antitumor prodrug and real-time intracellular tumor imaging.
    Li X; Mu J; Liu F; Tan EW; Khezri B; Webster RD; Yeow EK; Xing B
    Bioconjug Chem; 2015 May; 26(5):955-61. PubMed ID: 25938732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells.
    Qu F; Park S; Martinez K; Gray JL; Thowfeik FS; Lundeen JA; Kuhn AE; Charboneau DJ; Gerlach DL; Lockart MM; Law JA; Jernigan KL; Chambers N; Zeller M; Piro NA; Kassel WS; Schmehl RH; Paul JJ; Merino EJ; Kim Y; Papish ET
    Inorg Chem; 2017 Jul; 56(13):7519-7532. PubMed ID: 28636344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing luminescent ruthenium prodrug for precise cancer therapy and rapid clinical diagnosis.
    Zhao Z; Zhang X; Li CE; Chen T
    Biomaterials; 2019 Feb; 192():579-589. PubMed ID: 30551086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rigid 5'-6-locked phenanthroline-derived nucleosides chelated to ruthenium and europium ions.
    Gislason K; Sigurdsson ST
    Bioorg Med Chem Lett; 2013 Jan; 23(1):264-7. PubMed ID: 23177784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents.
    Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H
    Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
    Hu Y; Zeng F
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Lock-and-Kill Anticancer Photoactivated Chemotherapy Agent
    van Geest EP; Götzfried SK; Klein DM; Salitra N; Popal S; Husiev Y; Van der Griend CJ; Zhou X; Siegler MA; Schneider GF; Bonnet S
    Photochem Photobiol; 2023 Mar; 99(2):777-786. PubMed ID: 36315051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition Metal-Based Prodrugs for Anticancer Drug Delivery.
    Phillips AMF; Pombeiro AJL
    Curr Med Chem; 2019; 26(41):7476-7519. PubMed ID: 30501593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles.
    Ikuta Y; Koseki Y; Onodera T; Oikawa H; Kasai H
    Chem Commun (Camb); 2015 Aug; 51(64):12835-8. PubMed ID: 26165183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
    Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
    Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium-Containing Block Copolymer Assemblies: Red-Light-Responsive Metallopolymers with Tunable Nanostructures for Enhanced Cellular Uptake and Anticancer Phototherapy.
    Sun W; Parowatkin M; Steffen W; Butt HJ; Mailänder V; Wu S
    Adv Healthc Mater; 2016 Feb; 5(4):467-73. PubMed ID: 26680371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Click and Release: A High-Content Bioorthogonal Prodrug with Multiple Outputs.
    Ji X; Aghoghovbia RE; De La Cruz LKC; Pan Z; Yang X; Yu B; Wang B
    Org Lett; 2019 May; 21(10):3649-3652. PubMed ID: 31063383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A luminescent ruthenium(II) complex for light-triggered drug release and live cell imaging.
    Karaoun N; Renfrew AK
    Chem Commun (Camb); 2015 Sep; 51(74):14038-41. PubMed ID: 26248575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.